CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa

Conditions:   Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa, Junctional Interventions:   Device: CACIPLIQ20;   Drug: Placebo Sponsors:   Organ, Tissue, Regeneration, Repair and Replacement;   Euraxi Pharma;   ARANZ Medical Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials